.Attribute Medication, Published online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the observational SCRUM-Japan GOZILA study, after a median consequence of 11 months, clients with metastatic stomach growths that got biomarker-matched treatments based upon spreading cyst DNA profiling showed a greater professional benefit than those getting unparalleled therapy.